Back to search
FDAFDA · Food and drugs·Recall number D-1302-2022

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.

Published August 10, 2022 · Recall initiated: July 21, 2022

Summary

FDA records drug Class II recall D-1302-2022, published August 10, 2022 and initiated July 21, 2022. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 8022 bottles; Lot: Lot 1411593A, Exp 09/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: below specification limits for dissolution.

What to do

Voluntary: Firm initiated

Get an email if MATZIM LA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MATZIM LA
Manufacturer
Teva Pharmaceuticals USA Inc
Distributor
Nationwide in the USA and Puerto Rico
Lot
Lot 1411593A, Exp 09/22
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30. recalled?

Yes. FDA published recall D-1302-2022 on August 10, 2022. Reported hazard: Failed Dissolution Specifications: below specification limits for dissolution.

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MATZIM LA.